 |
|
|
Press Releases
Shands Jacksonville Medical
Center Joins Merge Technologies' Premier Partner Program
Milwaukee, WI, January 23, 2002
Merge Technologies Incorporated (NASDAQ: MRGE) today
announced that Shands Jacksonville Medical Center, Jacksonville
FL, has joined the Merge Premier Partner Program and
has become a new customer with the purchase of Merge's
PACSbuilder Radiology Workflow Solution. Shands is the
sixth clinical facility in the nation to join the program,
which is a collaborative effort between Merge and leading
clinical partners to continue development of Merge's
PACSbuilder solution. PACSbuilder is an integrated image
and information management workflow solution designed
to increase efficiencies, reduce costs and improve clinical
quality.
"PACSbuilder will allow us to better serve our
patients and referring physicians by integrating patient
information with radiology images and reports, and quickly
delivering this comprehensive information where and
when it is needed." said Arnold Friedman, Chief
of Radiology at Shands Jacksonville. "As a Premier
Partner and customer of Merge, we are joining a prestigious
group of healthcare facilities and will be among the
first in the nation to utilize leading edge technologies
that are designed to expedite and improve radiology
workflow."
Merge's Premier Partners are customers who continue
to purchase new PACSbuilder modules as they are developed
and launched. When elevated to Premier Partner status,
partners provide input into the development of future
radiology workflow solutions, receive a license to Merge's
advanced medical software development tools, and have
access to Merge's depth of healthcare informatics knowledge.
In exchange, Merge receives ongoing clinical input,
commercial rights for products co-developed with its
partners, and a worldwide network of prestigious clinical
trial and reference sites.
"Our Premier Partnership Program has become increasingly
important as we continue to develop and release modules
of our PACSbuilder solution," said Richard A. Linden,
Merge's President and CEO. "We are extremely excited
that Shands Hospital, along with Mallinckrodt Institute
of Radiology, Medical College of Wisconsin, UCLA Medical
Center, Jersey Shore Hospital and Methodist Hospital
of Memphis, has joined Merge in its effort to bring
high-quality, high-value radiology workflow solutions
to the marketplace."
Shands HealthCare and the University of Florida joined
forces in 1999 to form Shands Jacksonville - a place
where exemplary medical care is complemented by outstanding
service. With all the benefits of an academic medical
center, Shands Jacksonville offers advanced medical
treatment and the latest in research in a warm, caring
environment. In addition to its main campus at Shands
Jacksonville, the University of Florida has a network
of neighborhood care centers that provide quality care
in locations close to home or work.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
